NEW YORK (GenomeWeb News) – The prenatal genetic testing firm Natera said today that it has signed up Echevarne, a clinical analysis lab based in Barcelona, to offer its non-invasive prenatal screening test for chromosomal abnormalities to customers in Spain.

Under the distribution agreement, Echevarne's lab will offer the Natera Panorama test, which identifies trisomies 13, 18, and 21, as well as some sex chromosome abnormalities, to detect disorders like Down, Patau, Edwards, and Turner syndromes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.